- Home
- SLSN vs QTRX Comparison
SLSN vs QTRX Comparison
Compare SLSN & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLSN
- QTRX
- Stock Information
- Founded
- SLSN 1989
- QTRX 2007
- Country
- SLSN United States
- QTRX United States
- Employees
- SLSN N/A
- QTRX N/A
- Industry
- SLSN
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- SLSN
- QTRX Industrials
- Exchange
- SLSN NYSE
- QTRX Nasdaq
- Market Cap
- SLSN 218.7M
- QTRX 223.6M
- IPO Year
- SLSN N/A
- QTRX 2017
- Fundamental
- Price
- SLSN $3.36
- QTRX $5.51
- Analyst Decision
- SLSN
- QTRX Buy
- Analyst Count
- SLSN 0
- QTRX 5
- Target Price
- SLSN N/A
- QTRX $16.20
- AVG Volume (30 Days)
- SLSN 114.4K
- QTRX 640.4K
- Earning Date
- SLSN 05-05-2025
- QTRX 05-12-2025
- Dividend Yield
- SLSN N/A
- QTRX N/A
- EPS Growth
- SLSN N/A
- QTRX N/A
- EPS
- SLSN 0.05
- QTRX N/A
- Revenue
- SLSN $57,104,000.00
- QTRX $137,421,000.00
- Revenue This Year
- SLSN N/A
- QTRX $5.22
- Revenue Next Year
- SLSN N/A
- QTRX $15.31
- P/E Ratio
- SLSN $60.15
- QTRX N/A
- Revenue Growth
- SLSN 51.44
- QTRX 12.30
- 52 Week Low
- SLSN $1.56
- QTRX $4.67
- 52 Week High
- SLSN $3.36
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- SLSN N/A
- QTRX 45.05
- Support Level
- SLSN N/A
- QTRX $5.21
- Resistance Level
- SLSN N/A
- QTRX $6.09
- Average True Range (ATR)
- SLSN 0.00
- QTRX 0.40
- MACD
- SLSN 0.00
- QTRX 0.06
- Stochastic Oscillator
- SLSN 0.00
- QTRX 42.77
About SLSN SOLESENCE INC
Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.